Grand Mmti Fall 2019: Part 3. The Myeloma Immune Microenvironment Interaction With Car T Cells

Grand MMTI Fall 2019: Part 3. The Myeloma Immune Microenvironment Interaction with CAR T cells

Grand MMTI Fall 2019: Part 2. A Patient Experience with CAR T Cellular Therapy for Multiple Myeloma

Grand MMTI Fall 2019: Part 5. A Patient Experience with BiTE Immunotherapy for Multiple Myeloma

Grand MMTI Fall 2019: Part 1. Welcome and Program Overview

The future in multiple myeloma: BiTE immunotherapy, CAR-T, and immune checkpoint inhibitors

Activated T cell attacks a cancer cell

Nanolive, Looking inside life

ASH Annual Meeting: CAR-T and Multiple Myeloma

Armored CAR T cells in Multiple Myeloma

Targeted Oncology

Clinical Activity of BMS-986393, a CAR T cell therapy directed at GPRC5D, in Pts with RRMM

International Myeloma Foundation

What should care providers of myeloma patients know about CAR T-cell therapy?

International Myeloma Foundation

The potentially curative role of CAR-T therapy in myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Stockholm 2018: CAR T-cell Therapy

International Myeloma Foundation

The value of CAR-T cell therapy for the treatment of R/R multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

How are IMIDS and CELMODS being explored in Combo with CAR T-Cell therapy? #myeloma

HealthTree University for Multiple Myeloma

What are CAR-T cells? How are they made? #myeloma

HealthTree University for Multiple Myeloma

Dr. Smith Discusses CAR T Cells in Multiple Myeloma

The Latest Insights on Immune Therapies in Myeloma | 2023 IMF Patient and Family Seminar

International Myeloma Foundation

CAR T-Cells Multiple Myeloma: Adam Sperling, MD, PhD

Dana-Farber Cancer Institute

CAR T-Cell Therapy For Multiple Myeloma - Michael's Story - Nebraska Medicine

Nebraska Medicine Nebraska Medical Center

2019 Multiple Myeloma Symposium | Cellular Immunotherapy

Dana-Farber Cancer Institute